Rybelsus is now FDA-approved for managing cardiovascular health. Doctors say oral GLP-1s may reduce heart attack and stroke ...
Elinzanetant belongs to a new class of drugs designed to target what is believed to be a key mechanism responsible for ...
The U.S. Food and Drug Administration has approved Lynkuet, a new medication that does not contain hormones to treat hot ...
Big news in the menopause world: The Food and Drug Administration has just approved the drug elinzanetant as a non-hormonal ...
Low doses in mice have can clear up proteins associated with Alzheimer’s disease and restore memory. Human trials are the next step. Lithium has long been a standard treatment in bipolar disorder, but ...
The drug, elinzanetant, is expected to be available in the United States beginning in November under the brand name Lynkuet, ...
Everyday Health on MSN
FDA Approves Nonhormonal Pill for Menopausal Hot Flashes
Lynkuet (elinzanetant) may especially benefit some women with a history of breast cancer who are advised not to use hormone ...
A majority of PTSD sufferers—70 percent to almost 90 percent—develop sleep disturbances because they relive traumatic ...
The FDA says more than 580,000 bottles of a blood pressure medication have been recalled over concerns that it may contain a cancer-causing chemical.
A psychedelic-like therapy posted encouraging early data, as regulators cleared the drug — not a hallucinogenic — for at-home ...
Semaglutide, the active ingredient in Wegovy and Ozempic, lowers major cardiac event risk, regardless of how much weight a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results